|
Hokkaido University Collection of Scholarly and Academic Papers >
Institute for Genetic Medicine >
Peer-reviewed Journal Articles, etc >
Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S
| Title: | Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S |
| Authors: | Abe, Hirotake Browse this author | | Wada, Haruka Browse this author →KAKEN DB | | Baghdadi, Muhammad Browse this author | | Nakanishi, Sayaka Browse this author | | Usui, Yuu Browse this author | | Tsuchikawa, Takahiro Browse this author →KAKEN DB | | Shichinohe, Toshiaki Browse this author →KAKEN DB | | Hirano, Satoshi Browse this author →KAKEN DB | | Seino, Ken-ichiro Browse this author →KAKEN DB |
| Keywords: | Breast cancer | | 4T1 | | Immunogenicity | | Transformation |
| Issue Date: | Apr-2016 |
| Publisher: | Springer |
| Journal Title: | Human cell |
| Volume: | 29 |
| Issue: | 2 |
| Start Page: | 58 |
| End Page: | 66 |
| Publisher DOI: | 10.1007/s13577-015-0127-1 |
| PMID: | 26857856 |
| Abstract: | Cancer vaccines serve as a promising clinical immunotherapeutic strategy that help to trigger an effective and specific antitumor immune response compared to conventional therapies. However, poor immunogenicity of tumor cells remains a major obstacle for clinical application, and developing new methods to modify the immunogenicity of tumor cells may help to improve the clinical outcome of cancer vaccines. 4T1 mouse breast cancer cell line has been known as poorly immunogenic and highly metastatic cell line. Using this model, we identified a sub cell line of 4T1-designated as 4T1-Sapporo (4T1-S)-which shows immunogenic properties when used as a vaccine against the same line. In 4T1-S-vaccinated mice, subcutaneous injection of 4T1-S resulted in an antitumor inflammatory response represented by significant enlargement of draining lymph nodes, accompanied with increased frequencies of activated CD8 T cells and a subpopulation of myeloid cells. Additionally, 4T1-S vaccine was ineffective to induce tumor rejection in nude mice, which importantly indicate that 4T1-S vaccine rely on T cell response to induce tumor rejection. Further analysis to identify mechanisms that control tumor immunogenicity in this model may help to develop new methods for improving the efficacies of clinical cancer vaccines. |
| Rights: | The final publication is available at link.springer.com |
| Type: | article (author version) |
| URI: | http://hdl.handle.net/2115/64955 |
| Appears in Collections: | 遺伝子病制御研究所 (Institute for Genetic Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 清野 研一郎
|
